KM-219

N/A

Report date: 2024/10/25 17:14:37

Base Information

Drug NameKM-219
Drug Alias NameKM-219
ClassificationBiologics
Mechanisms of ActionEnvelope (E) protein modulators
TargetsEnvelope (E) protein
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Kangming Bio New Drug Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Kangming Bio New Drug Development Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A